Biotechnology industry expected to grow into a three billion dollar industry by 2002 ( The biotech products market in India is...)

Biotechnology industry expected to grow into a three billion dollar industry by 2002

The biotech products market in India is expected to grow into a three billion dollar industry by 2002 according to a Rabo India finance report. The big leap is expected to triple the industry's size from its 1999 value of one billion dollars. Biogenerics, biopharmaceuticals, agriculture, food and nutrition sectors are all poised for the big leap, both nationally and internationally.

The report said the global industry was expected to grow by 17% into 40 billion by 2005 and added that India needed to invest resources in academic and industrial biotech sectors both in research and development as well as infrastructure to harness its potential.

The report projected a pyramidal structure for the sector with a few top biotech (Pharma-biotech) companies with fully integrated manufacturing entities being supported by large number of service providers.

Page: 1
Related medicine news :

1. Biotechnology on the lead
2. Biologicals Transfer Proposal between US and Indian Biotechnology
3. Biotechnology Initiatives Planned In Hyderabad
4. Rhode Island Biotechnology Company Develops Tularemia Vaccine
5. Healthcare sector is now a multi billion-dollar industry in India
6. Setting up a new pharmaceutical industry in India
7. Drugs control and industry departments to share a common e-platform
8. Indian pharma industry upbeat on WTO drug deal
9. Cancer risk among nuclear industry workers
10. Collaborations planned between British Organization and Indian health care industry
11. Jharkhand Gives Health industry status

Post Your Comments:

(Date:5/16/2008)...INGTON, May 16 /PRNewswire-USNewswire/ -- As tropi... the Irrawaddy delta, survivors of,Cyclone Nargis ...ms. Many,survivors still need assistance, as expos...ing an increasingly dire situation., "The people ... to,recover from this disaster and get back on the...

(Date:5/16/2008)...peals for Funds Focus on Millions of Children Stil... U.S. Fund for UNICEF and The,Advertising Council ...omote,a series of national public service announce...ng Ben Stiller, Nicole Ritchie, Joel Madden, David...to help survivors of the,Myanmar cyclone. The Ad C...

(Date:5/16/2008)...ORT BEACH, Calif., May 16 /PRNewswire-FirstCall/ -... announced today the promotion of David,M. Boitano...ficer. "Dave,has made a tremendous contribution to...ur strong investment growth and diversification st...er $1 billion in accretive,investments for NHP, le...

(Date:5/16/2008)...DIEGO, May 16 /PRNewswire-FirstCall/ -- CryoCor, I...ed on the treatment of cardiac,arrhythmias, announ... of,CryoCor common stock filed a complaint in the ...of San Diego, naming as defendants each member of ...ton Scientific Corporation.,The complaint is style...

Breaking Medicine News(10 mins):Health News:Myanmar Cyclone Survivors Face New Challenges 2 Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 2 Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 3 Health News:David M. Boitano Promoted to Senior Vice President 2 Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 2 Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 3 Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 4

[0] Myanmar Cyclone Survivors Face New Challenges [0] Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities [0] David M. Boitano Promoted to Senior Vice President [0] CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger

... emergencies like predicting about the development...ts have devised a simulator, which could make star...u pandemic based on today's environment of worldwi...ientists from Los Alamos National Laboratory in Ne...

...a covering the provinces of Luanda, Bengo, Benguel... cholera outbreak on February 13, the number of re...of 48. // On Sunday WHO representative, Angola Fa...dicine and equipment to the Angolan Vice Minister ...

...by the NHS says a joint report from the Healthcare...on for Social Care Inspection. // Elder abuse is h... report said that old people are subject to patron... and carers. In hospital they are moved from one p...

...al has now proposed to let teenagers till the age ...ing repeatedly raised about the way young people a... turn 13. NHS, Greater Glasgow and Clyde is consid...ated at the children's hospital, and having suitab...

Other Medicine News:Health News:Supercomputers To Assist In Thwarting Bird Flu Epidemic In Future 2 Health News:Supercomputers To Assist In Thwarting Bird Flu Epidemic In Future 3 Health News:Supercomputers To Assist In Thwarting Bird Flu Epidemic In Future 4 Health News:Neglect of the Elderly by the Community 2

Supercomputers To Assist In Thwarting Bird Flu Epidemic In Future Death Toll due to Cholera Rises to 48 in Angola Neglect of the Elderly by the Community Older Teenagers Too To be Treated In Children’s Hospital

(Date:5/15/2008)...fety profile of BSI-201 in subject... May 15 /- BiPar Sciences, Inc., a,pr...novel cancer therapies,today announced that data ...be presented at the 2008 American Society of Clini... will be presented from the first in human Phase 1...

(Date:5/15/2008)...Call/ -- Schering-Plough,Corporation (NYSE: SGP )...of,chronic hepatitis C virus (HCV) infection, anno...s with PEGINTRON(TM) (peginterferon alfa-2b) and,R... well as boceprevir, the,company,s investigational...,the 39th annual Digestive Disease Week (DDW) meet...

(Date:5/15/2008).../ -- Ergonex Pharma today,announced that the Unite...anted orphan drug designation to Terguride for the...). Terguride is currently being evaluated for PAH,...s grant of orphan drug designation to Terguride fo...rogram by offering regulatory,clinical developmen...

(Date:5/15/2008)...ons Blue Cross Blue Shield of Michigan to Win... HealthLeaders-InterStudy, NASH...-InterStudy, the,leading provider of managed care ...ontinues to stagnate in Michigan, Blue Cross Blue ...l of its competitors to weather the,economic storm...

[0] BiPar Sciences Announces Clinical Data Presentations on Lead PARP Inhibitor, BSI-201, at 40th American Society of Clinical Oncology Annual Meeting [0] Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting [0] Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension [0] Blue Cross Blue Shield Of Michigan Battles Sluggish Economy With Diverse Product Lineup

..., Calif.--(BUSINESS WIRE)--May 8, 2007 - AVANIR,Ph...III data on the,efficacy, safety and improvements ...etic peripheral neuropathic (DPN) pain treated,wit...rphan /,quinidine) will be presented in two scient...on Neuropathic Pain, being held in,Berlin, Germany...

...DALE, Fla.--(BUSINESS WIRE)--May 9, 2007 - Regener...unced positive,results from several studies evalua...age-related macular degeneration (wet AMD) and,dia...sented this,week at the annual meeting of the Asso...ARVO). The data reported at the meeting,from a pre...

Other Medicine Technology:AVANIR Pharmaceuticals to Present Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at Second International Congress on,Neuropathic Pain 2 AVANIR Pharmaceuticals to Present Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at Second International Congress on,Neuropathic Pain 3 AVANIR Pharmaceuticals to Present Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at Second International Congress on,Neuropathic Pain 4 VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual,Meeting 2 VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual,Meeting 3 VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual,Meeting 4 VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual,Meeting 5

AVANIR Pharmaceuticals to Present Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at Second International Congress on,Neuropathic Pain VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual,Meeting

This therapeutic system is optimally designed with the patient in mind. As an alternative to surgery and ongoing therapy, SONOCUR Basic provides a low-risk and effective therapy. Plus, the patient re

As part of a new modular Endourological Platform concept, the Sonolith Praktis combines the latest technology developped in extracorporeal lithotripsy: electroconductivity, with a compact and innovat

... Easy to use and transportable, the Dornier Compac... both the user and the patient. The systems shock ...cal zone accuracy and avoid the risk of misalignme...e due to its motorized lateral and horizontal move...

The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean

Medicine Products:

SONOCUR Basic Sonolith Praktis Dornier Compact Delta Self-Cath® Plus Olive Tip Coude with Guide Stripe®

( The biotech products market in India is...)Biotechnology industry expected to grow into a three billion dollar industry by 2002,Health